Minneapolis Heart Institute Foundation

Summary

Minneapolis Heart Institute Foundation is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Heart Failure, Coronary Artery Disease, Heart Attack, Cardiovascular Disease, Von Willebrand Disease and other specialties. Minneapolis Heart Institute Foundation is involved with conducting 99 clinical trials across 178 conditions. There are 13 research doctors associated with this hospital, such as Santiago Garcia, MD, Paul Sorajja, MD, Jay Traverse, MD, and David Lin, Dr..

Top PIs

Clinical Trials running at Minneapolis Heart Institute Foundation

Heart Failure

Coronary Artery Disease

Cardiovascular Disease

Aortic Regurgitation

High Blood Pressure

Heart Disease

Mitral Valve Regurgitation

Mitral Regurgitation

Tricuspid Valve Regurgitation

Tricuspid Valve Disease

Reprieve System

for Heart Failure

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.

Recruiting

2 awards

Phase 3

3 criteria

Pulmonary Artery Sensor

for Heart Failure

This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial). The study contains of 5 arms: NYHA II Cohort - To demonstrate safety and efficacy of the Cordella PA Sensor System in NYHA Class II HF patients, where patients have daily access to PAP data. * Treatment Arm (Group 1) * Active Control Arm (Group 2) * Crossover Arm (Group 3) NYHA III Cohort - To demonstrate safety and efficacy of the Cordella PA Sensor System in NYHA Class III HF patients, where patients have daily access to PAP data, including a randomized sub-study to evaluate a clinician-directed patient self-management strategy.

Recruiting

1 award

N/A

10 criteria

ICD

for Heart Failure

The investigators aim to compare the risk of mortality of Non-implantable carioverter defibrillator (ICD) vs. ICD management in patients with heart failure with reduced ejection fraction (HFrEF).

Recruiting

1 award

N/A

1 criteria